September 8, 2023 Comments Off on New patent expiration for Merck Sharp drug TEMODAR Posted in: Uncategorized
Annual Drug Patent Expirations for TEMODAR Temodar is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are three…
The post New patent expiration for Merck Sharp drug TEMODAR appeared first on Dr…
September 8, 2023 Comments Off on New patent for APGDI drug MYRBETRIQ Posted in: Patent Added Annual Drug Patent Expirations for MYRBETRIQ Myrbetriq is a drug marketed by Apgdi and is included in two NDAs. It is available from three suppliers. There are seven patents protecting…
The post New patent for APGDI drug MYRBETRIQ appeared first on Dru…
